Glutathione is the supplement that’s genuinely important and genuinely over-marketed at the same time. It really is the cell’s master antioxidant — but that fact gets stretched into “detox,” “anti-aging” and “skin-whitening” claims that the evidence doesn’t support equally. The key, unusually, is the delivery route.
What it is
Glutathione (GSH) is a tripeptide — glutamate, cysteine and glycine — and the principal antioxidant inside your cells, where it neutralizes reactive oxygen species and recycles vitamins C and E. It declines with age and with oxidative stress, which is the entire basis for supplementing it. The long-standing skepticism was that swallowed glutathione is broken down in the gut before it can do anything — a claim that turns out to be only half true.
Oral glutathione: better evidence than its reputation
The best human data is a 6-month randomized controlled trial of oral glutathione (250 mg or 1000 mg/day) in 54 adults. It found GSH rose dose-dependently in blood, red cells and other tissues — roughly a 30–35% rise in the high-dose group by six months — with a marker of immune function improving too.[1] So chronic oral glutathione can raise your body stores. The catch the marketing skips: levels drifted back toward baseline about a month after people stopped, and the trial measured biomarkers, not disease outcomes or lifespan.
The skin-lightening claim
Glutathione is sold heavily as a skin-lightening agent, and here the honest read is “modest and temporary.” A systematic review of glutathione for skin-lightening and melasma found the effects are small, inconsistent across trials, and not durable once you stop.[3] It isn’t nothing, but it’s a long way from the dramatic, permanent whitening the products imply.
IV glutathione: the most marketed, least proven
Intravenous glutathione is the wellness- and aesthetic-clinic favorite — and the weakest-evidenced route. There are essentially no outcome RCTs for IV glutathione’s marketed uses — the systematic review found a single placebo-controlled IV study, in which 6 of 16 patients responded against 3 of 16 on placebo (37.5% vs 18.7%, p = 0.054), and concluded IV glutathione is contraindicated for lack of efficacy.[3] Reviewers have separately flagged inadequate safety data, with case reports of skin reactions and other adverse effects; some regulators have warned against off-label IV use for skin-whitening.[4] It’s the highest-cost, highest-hype, lowest-data form. The severe reactions on record — Stevens-Johnson syndrome and toxic epidermal necrolysis, thyroid dysfunction, kidney injury, and infection from non-sterile infusions — cluster around this whitening market rather than around the oral capsule, a split we lay out route by route in glutathione’s side effects.
| Route / claim | What the evidence supports |
|---|---|
| Oral GSH raises body stores | Yes — a 6-month RCT, dose-dependent (reverses on stopping) |
| Precursors (GlyNAC) raise GSH | Yes — mechanistically sound, biomarker improvements |
| Skin lightening | Modest, inconsistent, not durable |
| IV glutathione benefits | Weakest evidence; safety data inadequate |
| Detox / anti-aging / longevity | Not demonstrated in human outcome trials |
The honest bottom line
Glutathione is real, central antioxidant biochemistry, and oral supplementation genuinely raises your stores — better than the old skeptic line claimed.[1] But “raises a biomarker” is not “extends healthspan”: no human trial shows oral, liposomal or IV glutathione prevents disease or slows aging in healthy people, the skin effects are modest and reversible, and IV is the least-evidenced route of all.[4] If your goal is to support glutathione, the precursor route (GlyNAC) is the more rational bet. It sits in the same broad antioxidant-support category as molecular hydrogen — a different, more selective mechanism with its own thin but real human trial record — and you can weigh it against the rest in our longevity evidence matrix. For where it’s offered clinically, see our NAD⁺ & longevity provider roundup.